Cn /En

Tumor and Tumor Immunity Personalized Clinical Drug Screening


  Chuangmo Biotech, based on its unique inno-PDC and inno-PDX platforms, can provide clinical drug screening services for tumor patients regarding tumor and tumor immunotherapy.

  PDC chemotherapy/targeted drug efficacy prediction

  ● Can evaluate the efficacy of chemotherapy and targeted drugs.

  ● Testing is completed within a week, ensuring timeliness.

  ● The experimental process is simple and quick, with minimal impact on the activity of tumor cells. After obtaining sufficient tumor cells from patients, the success rate of the experiment is 100%.

  ● Can provide effective references for subsequent in vivo efficacy evaluation and clinical treatment.

  PDC immunotherapy drug efficacy prediction

  ● A leading domestic clinical drug screening platform for tumor immunotherapy.

  ● Simultaneously tests the patient's own tumor and immune system.

  ● Testing is completed within a week, ensuring timeliness.

  ● The experimental process is simple and quick, with minimal impact on the activity of tumor cells. After obtaining sufficient tumor cells from patients, the success rate of the experiment is 100%.

  ● Can provide effective references for subsequent in vivo efficacy evaluation and clinical treatment.